112 related articles for article (PubMed ID: 27913051)
1. ERG expression in multiple myeloma-A potential diagnostic pitfall.
Knief J; Reddemann K; Gliemroth J; Brede S; Bartscht T; Thorns C
Pathol Res Pract; 2017 Feb; 213(2):130-132. PubMed ID: 27913051
[TBL] [Abstract][Full Text] [Related]
2. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
[TBL] [Abstract][Full Text] [Related]
3. ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.
Shah RB; Li J; Dhanani N; Mendrinos S
Urol Oncol; 2016 Mar; 34(3):120.e1-7. PubMed ID: 26585946
[TBL] [Abstract][Full Text] [Related]
4. [Solitary plasmacytoma of spine: a clinical, radiologic and pathologic study of 13 cases].
He MX; Zhu MH; Zhang YM; Fu QG; Wu LL
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):307-11. PubMed ID: 19575872
[TBL] [Abstract][Full Text] [Related]
5. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
6. CD31 expression in plasmacytic/plasmablastic lesions.
Plocharczyk E; Wakely PE
Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases].
Su XY; Xu X; Tang Y; Li GD
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):542-6. PubMed ID: 20021966
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
Downes MR; Satturwar S; Trudel D; van der Kwast TH
Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
10. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
12. Testicular and epididymal plasmacytoma: a report of 7 cases, including three that were the initial manifestation of plasma cell myeloma.
Ferry JA; Young RH; Scully RE
Am J Surg Pathol; 1997 May; 21(5):590-8. PubMed ID: 9158685
[TBL] [Abstract][Full Text] [Related]
13. ERG protein expression as a biomarker of prostate cancer.
Falzarano SM; Magi-Galluzzi C
Biomark Med; 2013 Dec; 7(6):851-65. PubMed ID: 24266818
[TBL] [Abstract][Full Text] [Related]
14. ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer.
Berg KD; Vainer B; Thomsen FB; Røder MA; Gerds TA; Toft BG; Brasso K; Iversen P
Eur Urol; 2014 Nov; 66(5):851-60. PubMed ID: 24630684
[TBL] [Abstract][Full Text] [Related]
15. Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook.
Suryavanshi M; Mehta A; Jaipuria J; Sharma AK; Rawal S; Seth N
Urol Oncol; 2015 Jul; 33(7):331.e9-15. PubMed ID: 25899828
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
Shah RB; Tadros Y; Brummell B; Zhou M
Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the prostate with multiple osteolytic metastases simulating multiple myeloma. A case report.
Maharaj B; Kalideen JM; Leary WP; Pudifin DJ
S Afr Med J; 1986 Aug; 70(4):227-8. PubMed ID: 3738661
[TBL] [Abstract][Full Text] [Related]
18. Recognizing Oral Manifestations of Multiple Myeloma.
Jhamb T; Syed AZ; Baur D
J Mass Dent Soc; 2015; 64(1):18-9. PubMed ID: 26168529
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
Terry S; Nicolaiew N; Basset V; Semprez F; Soyeux P; Maillé P; Vacherot F; Ploussard G; Londoño-Vallejo A; de la Taille A; Allory Y
Cancer; 2015 May; 121(9):1422-30. PubMed ID: 25639219
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
Shah RB; Bentley J; Jeffery Z; DeMarzo AM
Hum Pathol; 2015 May; 46(5):698-706. PubMed ID: 25724568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]